Literature DB >> 1640166

The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus.

S Baruchel1, M A Wainberg.   

Abstract

This review describes the potential role of oxidative stress as a cofactor of disease progression from asymptomatic human immunodeficiency virus (HIV) infection to the acquired immunodeficiency syndrome (AIDS). Oxidative stress is a known activator of HIV replication in vitro through the activation of a factor that binds to a DNA-binding protein, NF-kappa B, which in turn stimulates HIV gene expression by acting on the promoter region of the viral long terminal repeat. Tumor necrosis factor alpha (TNF-alpha), an essential cytokine produced by activated macrophages, is also involved in the activation of HIV infection through similar mechanisms. TNF-mediated cytotoxicity of cells exposed to this substance is related to the generation of intracellular hydroxyl radicals. An indirect argument in favor of the role of oxidative stress in HIV-associated disease progression is the consumption of glutathione (GSH), a major intracellular antioxidant, during HIV infection and progression. GSH is known to play a major role in regulation of T cell immune functions. Oxidative stress may also play an important role in the genesis of cellular DNA damage and, in this context, may be related to HIV-associated malignancies and disease progression. Finally, the role of antioxidants as components of therapeutic strategies to combat HIV disease progression is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640166     DOI: 10.1002/jlb.52.1.111

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  27 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

2.  The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth.

Authors:  Ryan D Michalek; S Troy Pellom; Beth C Holbrook; Jason M Grayson
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

Review 3.  Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV.

Authors:  Y Wang; R R Watson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

4.  Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity.

Authors:  P S S Rao; Santosh Kumar
Journal:  Alcohol Clin Exp Res       Date:  2016-01       Impact factor: 3.455

5.  Interaction of porcine circovirus type 2 replication with intracellular redox status in vitro.

Authors:  Xingxiang Chen; Fei Ren; John Hesketh; Xiuli Shi; Junxian Li; Fang Gan; Zhihua Hu; Kehe Huang
Journal:  Redox Rep       Date:  2013-07-23       Impact factor: 4.412

6.  Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load.

Authors:  C Elbim; S Pillet; M H Prevost; A Preira; P M Girard; N Rogine; H Matusani; J Hakim; N Israel; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection.

Authors:  Z Zhang; M Araghi-Niknam; B Liang; P Inserra; S K Ardestani; S Jiang; S Chow; R R Watson
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

8.  Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.

Authors:  Erik R Kline; Dean J Kleinhenz; Bill Liang; Sergey Dikalov; David M Guidot; C Michael Hart; Dean P Jones; Roy L Sutliff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 9.  The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.

Authors:  Erik R Kline; Roy L Sutliff
Journal:  J Investig Med       Date:  2008-06       Impact factor: 2.895

10.  Reconciling conflicting clinical studies of antioxidant supplementation as HIV therapy: a mathematical approach.

Authors:  Rolina D van Gaalen; Lindi M Wahl
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.